A new study aiming to understand sarcoidosis-associated pulmonary hypertension symptoms and their impacts on patients’ lives determined that the Pulmonary Arterial Hypertension-Symptoms and Impact ...

While diagnostic algorithms have evolved in the last decade, there remains an urgent need for innovative therapeutic options to treat systemic sclerosis with pulmonary arterial hypertension. Patients ...

BOSTON -- Pulmonary artery denervation improved symptoms in pulmonary arterial hypertension (PAH), a clinical trial from China showed. The radiofrequency ablation procedure increased 6-minute walk ...

A 40-year-old woman who was a frequent traveler suddenly found herself struggling to breathe after taking just a few steps. What began as unexplained fatigue and shortness of breath quickly disrupted ...

Please provide your email address to receive an email when new articles are posted on . As understanding of pulmonary arterial hypertension grows and novel therapies emerge, the treatment of PAH ...

Doctors in Germany could have achieved a breakthrough as they treated a young girl suffering from a severe pulmonary condition that can lead to heart failure, by applying umbilical cord stem cell ...

For Erin, pulmonary arterial hypertension isn’t just a diagnosis, it’s been a lifelong presence. Her journey spans family ...

Patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs, who were treated with the novel first-in-class medication sotatercept on top of ...

The interim results of a phase 3 trial of Merck’s pulmonary arterial hypertension (PAH) treatment Winrevair were so conclusive that the company not only halted the study for efficacy, but did the same ...

Merck MRK announced that the phase III HYPERION study evaluating its pulmonary arterial hypertension (“PAH”) drug, Winrevair (sotatercept), in newly diagnosed intermediate or high-risk PAH patients, ...